Beyond the Numbers: Diagnostic Precision and Biological Endotypes in Pulmonary Arterial Hypertension/ Samuel G. Rayner (Univ. of Washington, USA) Treatment Goals for PAH / Hiromi Matsubara (NHO Okayama Medical Center, Japan) PAH with cardiopulmonary comorbidities: Importance of patient-specific treatment goal / Takahiro Hiraide (Keio Univ. School of Medicine, Japan) The changing treatment paradigm in pulmonary hypertension / Stephan Rosenkranz (Univ. of Cologne, Germany) |